Campbell. We do begin with breaking news out of antioch where Authorities Say a Police Officer shot and wounded a suspect there this morning. It happened around 8 50 a. M. At a home on folsom drive near spaulding street. The suspect was taken to the hospital in walnut creek. No word on his condition. Police have not said what prompted the shooting or if anyone else was injured. Well bring you more details on the news at 5 00 and 6 00 as well as twitter and facebook. Well, today, more than four years since the deadly gas line explosion in san bruno killed eight people, city ed lookers released city leaders released criticisms for firings, fines and punishments aimed at the cpuc. Tom vacar is live in the newsroom to tell us more about the newly released details alleging an inappropriate relationship. If the city is right, the cpuc may not survive the san bruno blast. A relationship much deeper and more shocking than even we originally figured. The city of san bruno revealed the contents
Exscientia fires CEO—Chutes & Ladders fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
CAMBRIDGE, Mass. (BUSINESS WIRE) Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced the appointm.
Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph D to Chief Scientific Officer lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
Announced encouraging safety and efficacy data in ongoing Phase 1 study of ADI-001 for the potential treatment of relapsed or refractory B-cell non-Hodgkin’s lymphoma (NHL)On track to report a clinical update for ADI-001 in second half of 2024Plan to file Investigational New Drug Application (IND) for ADI-925 in H2.